2018 Specialty Rx Forum Program


7:00 am REGISTRATION OPENS (continental breakfast)
8:15 am - 8:30 am

Opening Remarks

Jane Lutz, Executive Director
PBMI
8:30 am - 9:15 am

How Specialty Pharmacy is Changing the Supply Chain

Albert Thigpen, President and Chief Operating Officer
CastiaRx

The needs of specialty patients extend beyond traditional pharmacy benefit management. Join us and hear how the industry is evolving and how high touch care management plays a vital role in their healthcare.

9:15 am - 10:00 am

Journey of an MS Specialty Patient

Executive Medical Director
Schapiro Center for Multiple Sclerosis, Minneapolis Clinic of Neurology

Patient

Moderator: Cheryl Larson, President & CEO
Midwest Business Group on Health


Hear a firsthand account about the everyday challenges a specialty patient faces.

10:00 am - 10:15 am  MORNING BREAK
10:15 am - 11:00 am 

Specialty Conditions and Targeted Interventions Driven From Data

Christine Anderson, RPh, Vice President of Specialty Products 
EnvisionRx

The speaker will outline which specialty therapies make the most logical choices for intervention and will provide specific outcomes data related to such interventions. 

11:00 am - 11:45 am

Delivering Value Through Specialty Trend Management  

Michelle Leibow, Director Product Development
AllianceRx Walgreens Prime
 

This session will address how to deliver value and reduce total healthcare cost through specialty trend management.

12:00 pm - 1:00 pm  LUNCH
1:00 pm - 1:30 pm 

Specialty Drug Management: What Employers Want

Linda Davis, BS Nursing, Consultant
Davis Consulting
Bithia Anderson, PharmD, MPA, Assistant Director
PRIME Institute, University of Minnesota College of Pharmacy

The speakers will describe the top 20 goals of MN Health Action Group employers related to specialty drug management by health plans, providers, PBMs, specialty pharmacies, and manufacturers.  In addition, they will describe proceedings, insights, and progress in turning these goals into action with the support of a multi-stakeholder group, the Specialty Drug Guiding Coalition.

1:30 pm - 2:30 pm 

Moderated Employer Panel: Plan Sponsor Perspectives/Success Stories 

John X. Toth, RPh, BS Pharm, Manager Pharmacy Program Development
Yale Health

Stephen Lott, PharmD, MS, Clinical Pharmacist Specialist
University of Michigan Prescription Drug Plan

Moderator: Tracy Spencer, SVP & Practice Leader, Employer Consulting
Pharmaceutical Strategies Group

2:30 pm - 2:45 pm AFTERNOON BREAK
2:45 pm - 3:30 pm 

Orphan Diseases: Managing High Cost Therapies and Providing Important Clinical Care Solutions

Steve Avey, MS, FAMCP, Vice President, Enterprise Specialty Clinical Solutions
Susan Trieu, PharmD, Director Enterprise Specialty Clinical Solutions
MedImpact Health Systems

New orphan disease therapies come with substantial costs that have brought greater scrutiny from payers.  While medication cost management is critical, it is also important to understand the impact of the diseases on members and develop strategies to mitigate negative health consequences that further drive up overall medical spend.  This session will highlight the health consequences of orphan diseases such as hemophilia and cystic fibrosis.  

3:30 pm - 4:15 pm 

Cracking the Code on Gene Therapy

Meghan Pasicznyk, PharmD, MBA, Senior Director, Specialty Market Development
Express Scripts

The advent of gene therapy holds incredible promise for patients, but payers must understand the implications of a rapidly growing and changing market.  Join us as we demystify these revolutionary new drugs and discuss potential management strategies.

4:15 pm - 4:30 pm 

Closing Remarks 

Jane Lutz, Executive Director
PBMI

4:30 pm - 5:30 pm 

Networking Reception

  Subject to change